Day Trading Stocks & Futures

[against_tides]

CIPLA up 10 %.........Auro Pharma 5% up...anything with name pharma in it is shooting up......SBI ka naam SBI pharma karo tho upper circuit lag jaye.....

how about yespharma??

 

[midhoo]

Is these data helpful to make our trading decisions? Like we should not go against majority.

 

[siddhant4u]

how about yespharma??

yes bank to pahale hi UC hai...

 

[travi]

how about yespharma??

22Cr Vol and 7 Cr at UC
mauje hi mauje

 

[against_tides]

22Cr Vol and 7 Cr at UC
mauje hi mauje

ask oldie long term investors

 

[travi]

ask oldie long term investors

no need to ask. Even they should be happy because portf is about stock selection.

If 1-2 become 0 also, it doesn't matter in LT pf
And there is no point asking those oldies who bought only yespharma and thought it will take them to the moon

 

[Dr. Jan Itor]

agr sc hearing postponed to 3 pm... affects bharti, idea...

 

[Dr. Jan Itor]

Any views on Concor for medium term??

Concor shares plunge 18% after posting 76% drop in Q1 profit
Total income during the April-June period of the current fiscal dipped to Rs 1,251.50 crore from Rs 1,722.79 crore in the year-ago period

https://www.business-standard.com/a...drop-decline-in-q1-profit-120081000318_1.html

 

[travi]

Any views on Concor for medium term??

Concor shares plunge 18% after posting 76% drop in Q1 profit
Total income during the April-June period of the current fiscal dipped to Rs 1,251.50 crore from Rs 1,722.79 crore in the year-ago period

https://www.business-standard.com/a...drop-decline-in-q1-profit-120081000318_1.html

I've learnt here that one should avoid Sarkari stocks and Medium term falls in that category. short/pos is still ok. I have an exception of holding IRCTC.

Apart from that, it has a niche business and its critical too. Covid shutdown has affected it more than any fundamental problem.
So buying low in this one isn't a bad idea.
Sarkari businesses have the advantage of unlimited oxygen supply.

 

[siddhant4u]

AMC's soon will be in trouble...

https://www.livemint.com/market/sto...w-in-over-6-years-in-july-11597055021857.html

Inflows into equity schemes have been slowing down after the robust net of ₹12,175.04 crore seen in March. In June, net inflows were at ₹240.55 crore, the lowest in 51 months. In July last year, these funds received ₹8,133.21 crore worth of net inflows.

Last month, redemption pressure deepened while contribution from systematic investment plan (SIP) continued to dwindle. Net redemptions in equity mutual fund schemes rose to a four-month high of ₹16,622.01 crore in July, up 22.9% from ₹13,520.03 crore in previous month and from ₹12,173.81 crore in the year-ago period. SIP inflow fell to ₹7,830.66 crore in July from ₹7,927.11 crore in June.